Table 2 Frequency distribution of second-step intervention by initial monotherapy SSRI treatment
Second-step intervention | Initial monotherapy treatment | ||||||
|---|---|---|---|---|---|---|---|
Citalopram hydrochloride | Sertraline hydrochloride | Escitalopram oxalate | Fluoxetine hydrochloride | Paroxetine hydrochloride/mesylate | Fluvoxamine | Total | |
N = 1,510 | N = 1,380 | N = 936 | N = 899 | N = 272 | N = 15 | N = 5,012 | |
n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | |
Continued | 469 (31.1) | 425 (30.8) | 295 (31.5) | 286 (31.8) | 66 (24.3) | 4 (26.7) | 1,545 (30.8) |
Discontinued | 266 (17.6) | 207 (15.0) | 137 (14.6) | 145 (16.1) | 43 (15.9) | 4 (26.7) | 802 (16.0) |
Switch | 254 (16.8) | 206 (14.9) | 138 (14.7) | 120 (13.3) | 48 (17.6) | 5 (33.3) | 771 (15.4) |
Add-on | 521 (34.5) | 542 (39.3) | 366 (39.1) | 348 (38.7) | 115 (42.3) | 2 (13.3) | 1,894 (37.8) |